TGA rejects demand for OTC oral contraceptives
The watchdog warned that women could miss out on preventive care such as cervical cancer screening
The latest bid for oral contraceptives to be sold over the counter in pharmacies has failed, with the TGA warning that women will miss out on HPV tests and other preventive health screening.
The regulator also stressed that the risk of adverse events associated with the substances such as venous thromboembolism and heavy bleeding confirmed the need for GP oversight.
